This inventor holds 1 USPTO granted patent. Top assignees: Kyoto University, National Cancer Center, Otsuka Pharmaceutical Company, Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 873 
1 out of 264 
1 out of 846 
Years Active: 2021
Title: Manabu Muto and His Patent on Evaluating Chemoradiotherapy
Introduction
Manabu Muto is an inventor associated with Kyoto, Japan. His work includes a patented method for evaluating the efficacy of chemoradiotherapy against squamous cell carcinoma.
Latest Patents
Muto is associated with 1 patent: “Method for Evaluating Efficacy of Chemoradiotherapy Against Squamous Cell Carcinoma.” The method describes steps for assessing how effectively chemoradiotherapy treats squamous cell carcinoma.
Career Highlights
Muto’s listed institutional affiliations include Kyoto University and the National Cancer Center. These organizations are associated with research and medical work relevant to his patent.
Collaborations
His listed coworkers include Kazuhiko Aoyagi and Hiroki Sasaki.
Conclusion
Manabu Muto’s patent focuses on evaluating chemoradiotherapy efficacy against squamous cell carcinoma, reflecting a contribution at the intersection of cancer treatment and assessment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile